BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31991332)

  • 1. High serum substance P levels and mortality after malignant middle cerebral artery infarction.
    Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Argueso M; Ramos L; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    J Crit Care; 2020 Jun; 57():1-4. PubMed ID: 31991332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients.
    Lorente L; Martín MM; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A; Borreguero-León JM; González-Rivero AF; Orbe J; Rodríguez JA; Páramo JA
    BMC Neurol; 2019 Jul; 19(1):167. PubMed ID: 31319804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Caspase-3 Levels and Early Mortality of Patients with Malignant Middle Cerebral Artery Infarction.
    Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Sabatel R; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    Neurocrit Care; 2019 Dec; 31(3):486-493. PubMed ID: 31115825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High serum levels of caspase-cleaved cytokeratin-18 are associated with malignant middle cerebral artery infarction patient mortality.
    Lorente L; Martín MM; Pérez-Cejas A; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    BMC Neurol; 2018 Mar; 18(1):32. PubMed ID: 29573748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-survivor patients with malignant middle cerebral artery infarction showed persistently high serum malondialdehyde levels.
    Lorente L; Martín MM; Abreu-González P; Sabatel R; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    BMC Neurol; 2019 Oct; 19(1):238. PubMed ID: 31623565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum malondialdehyde levels in patients with malignant middle cerebral artery infarction are associated with mortality.
    Lorente L; Martín MM; Abreu-González P; Ramos L; Argueso M; Solé-Violán J; Riaño-Ruiz M; Jiménez A
    PLoS One; 2015; 10(5):e0125893. PubMed ID: 25933254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Levels of Substance P and Mortality in Patients with a Severe Acute Ischemic Stroke.
    Lorente L; Martín MM; Almeida T; Pérez-Cejas A; Ramos L; Argueso M; Riaño-Ruiz M; Solé-Violán J; Hernández M
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher Serum Melatonin Levels during the First Week of Malignant Middle Cerebral Artery Infarction in Non-Surviving Patients.
    Lorente L; Martín MM; Abreu-González P; Sabatel R; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    Brain Sci; 2019 Nov; 9(12):. PubMed ID: 31795260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Serum sCD40L Levels During the First Week of Malignant Middle Cerebral Artery Infarction and Mortality.
    Lorente L; Martín MM; González-Rivero AF; Sabatel R; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Alvarez-Castillo A; Jiménez A; Borreguero-León JM; García-Marín V
    World Neurosurg; 2019 Dec; 132():e630-e636. PubMed ID: 31442656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Survivor Ischemic Stroke Patients Maintain High Serum Caspase-Cleaved Cytokeratin-18 Levels.
    Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Sabatel R; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    Brain Sci; 2020 Feb; 10(3):. PubMed ID: 32120809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Levels of B-cell Lymphoma-2 Anti-Apoptotic Protein and Malignant Middle Cerebral Artery Infarction Mortality.
    Lorente L; Martín MM; González-Rivero AF; Pérez-Cejas A; Ramos-Gómez L; Solé-Violán J; Cáceres JJ; Villacampa-Jiménez JJ; Jiménez A
    J Stroke Cerebrovasc Dis; 2021 May; 30(5):105717. PubMed ID: 33690027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Serum Soluble CD154 Levels and Mortality in Patients with Malignant Middle Cerebral Artery Infarction.
    Lorente L; Martín MM; González-Rivero AF; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A; Borreguero-León JM
    Int J Mol Sci; 2015 May; 16(6):12147-58. PubMed ID: 26030673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction.
    Lorente L; Martín MM; Ramos L; Cáceres JJ; Solé-Violán J; Argueso M; Jiménez A; Borreguero-León JM; Orbe J; Rodríguez JA; Páramo JA
    BMC Neurol; 2015 Jul; 15():111. PubMed ID: 26162891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum melatonin levels are associated with mortality in patients with malignant middle cerebral artery infarction.
    Lorente L; Martín MM; Abreu-González P; Pérez-Cejas A; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    J Int Med Res; 2018 Aug; 46(8):3268-3277. PubMed ID: 29848129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between blood caspase-8 levels and mortality of patients with malignant middle cerebral artery infarction.
    Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Ramos-Gómez L; Solé-Violán J; Cáceres JJ; Villacampa-Jiménez JJ; Jiménez A
    Med Intensiva (Engl Ed); 2022 Jun; 46(6):305-311. PubMed ID: 35688578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of Decompressive Craniectomy for Malignant Middle Cerebral Artery Infarction: A Single-Center Analysis.
    Kilic M; Ertem DH; Ozdemir B
    Medicina (Kaunas); 2019 Jan; 55(2):. PubMed ID: 30704138
    [No Abstract]   [Full Text] [Related]  

  • 17. Poor Collateral Circulation Assessed by Multiphase Computed Tomographic Angiography Predicts Malignant Middle Cerebral Artery Evolution After Reperfusion Therapies.
    Flores A; Rubiera M; Ribó M; Pagola J; Rodriguez-Luna D; Muchada M; Boned S; Seró L; Sanjuan E; Meler P; Carcámo D; Santamarina E; Tomassello A; Lemus M; Coscojuela P; Molina CA
    Stroke; 2015 Nov; 46(11):3149-53. PubMed ID: 26419969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood soluble Fas concentrations and ischemic stroke patient mortality.
    Lorente L; Martín MM; Pérez-Cejas A; Ferrer-Moure C; Ramos-Gómez L; Solé-Violán J; Cáceres JJ; Jiménez A; González-Rivero AF
    Expert Rev Mol Diagn; 2022 Dec; 22(12):1117-1121. PubMed ID: 36621530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between blood caspase-8 levels and mortality of patients with malignant middle cerebral artery infarction.
    Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Ramos-Gómez L; Solé-Violán J; Cáceres JJ; Villacampa-Jiménez JJ; Jiménez A
    Med Intensiva (Engl Ed); 2021 Apr; ():. PubMed ID: 33926751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum substance P levels and early mortality of spontaneous intracerebral haemorrhage patients.
    Lorente L; Martín MM; González-Rivero AF; Pérez-Cejas A; Sabatel R; Ramos-Gómez L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A; García-Marín V
    J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104893. PubMed ID: 32414584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.